PMID- 31315894 OWN - NLM STAT- MEDLINE DCOM- 20191223 LR - 20221207 IS - 1472-4146 (Electronic) IS - 0021-9746 (Linking) VI - 73 IP - 1 DP - 2020 Jan TI - Detection of human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7) DNA in endocervical samples from a positive and negative HPV woman of Cordoba, Argentina. PG - 30-34 LID - 10.1136/jclinpath-2019-205795 [doi] AB - AIMS: The purpose of the present study was to elucidate the presence of human herpesvirus 6A (HHV-6A), HHV-6B and HHV-7 in samples of the uterine cervix through detection of viral DNA. We analysed normal tissues, samples with low-grade squamous intraepithelial lesions (LSILs) and high-grade squamous intraepithelial lesions (HSILs). We correlated the presence of HHV-6 and HHV-7 with the finding of human papillomavirus (HPV) in mucosal samples. METHODS: Cervical samples were examined and grouped as follows: group 1 (n=29), normal cytology; group 2 (n=61), samples with LSIL; group 3 (n=35), samples with HSIL. Molecular biology examinations were performed in all samples to detect HHV-6, HHV-7 and HPV DNA and to typify HHV-6 species. RESULTS: Group 1: normal cytology and HPV (-): HHV-6: 6.8% (2/29), HHV-7: 79.3% (23/29); group 2: LSIL and HPV (-): HHV-6: 93.1% (27/29), HHV-7: 96.5% (28/29); LSIL and HPV (+): HHV-6: 0% (0/32), HHV-7: 90.6% (29/32); group 3: HSIL and HPV (-): HHV-6: 20% (2/10), HHV-7: 70% (7/10); HSIL HPV (+): HHV-6: 12% (3/25), HHV-7: 68% (17/25). HHV-6A DNA was not detected in any samples. CONCLUSIONS: (1) Both HHV-6 and HHV-7 infect the mucosal cells of the cervix with higher prevalence of HHV-7. (2) The higher prevalence of HHV-6 in LSIL HPV (-) samples compared with those with normal cytology indicates that it constitutes a possible risk factor for atypia production. (3) The presence of HHV-7 in all samples questions its role in the production of atypia. (4) The finding of HHV-6 and HHV-7 suggests that the cervical mucosa is a possible transmission pathway for these viruses. CI - (c) Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. FAU - Biganzoli, Patricia AU - Biganzoli P AUID- ORCID: 0000-0002-4902-6813 AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina patricia.biganzoli@gmail.com. AD - Medical Bacteriology and Virology, School of Medical Sciences, National University of Cordoba, Cordoba, Argentina. FAU - Frutos, Maria Celia AU - Frutos MC AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. FAU - Venezuela, Fernando AU - Venezuela F AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. FAU - Mosmann, Jessica AU - Mosmann J AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. FAU - Kiguen, Ana AU - Kiguen A AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. FAU - Pavan, Jorge AU - Pavan J AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. AD - Medical Bacteriology and Virology, School of Medical Sciences, National University of Cordoba, Cordoba, Argentina. FAU - Ferreyra, Leonardo AU - Ferreyra L AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. AD - Medical Bacteriology and Virology, School of Medical Sciences, National University of Cordoba, Cordoba, Argentina. FAU - Cuffini, Cecilia AU - Cuffini C AD - Virology Institute 'Dr. J. Vanella', School of Medical Sciences, National University of Cordoba, Cordoba, Cordoba, Argentina. LA - eng PT - Journal Article DEP - 20190717 PL - England TA - J Clin Pathol JT - Journal of clinical pathology JID - 0376601 RN - 0 (DNA, Viral) SB - IM MH - Adolescent MH - Adult MH - Argentina MH - DNA, Viral/*genetics MH - Female MH - Herpesvirus 6, Human/*genetics MH - Herpesvirus 7, Human/*genetics MH - Human Papillomavirus DNA Tests MH - Humans MH - Middle Aged MH - *Molecular Diagnostic Techniques MH - Papillomaviridae/genetics MH - Papillomavirus Infections/diagnosis/genetics/virology MH - Predictive Value of Tests MH - Prognosis MH - Retrospective Studies MH - Roseolovirus Infections/*diagnosis/genetics/transmission/virology MH - Squamous Intraepithelial Lesions of the Cervix/*diagnosis/genetics/virology MH - Uterine Cervical Neoplasms/*diagnosis/genetics/virology MH - Young Adult MH - Uterine Cervical Dysplasia/*diagnosis/genetics/virology OTO - NOTNLM OT - gynecological pathology OT - human papillomavirus OT - virus COIS- Competing interests: None declared. EDAT- 2019/07/19 06:00 MHDA- 2019/12/24 06:00 CRDT- 2019/07/19 06:00 PHST- 2019/02/21 00:00 [received] PHST- 2019/06/24 00:00 [revised] PHST- 2019/06/28 00:00 [accepted] PHST- 2019/07/19 06:00 [pubmed] PHST- 2019/12/24 06:00 [medline] PHST- 2019/07/19 06:00 [entrez] AID - jclinpath-2019-205795 [pii] AID - 10.1136/jclinpath-2019-205795 [doi] PST - ppublish SO - J Clin Pathol. 2020 Jan;73(1):30-34. doi: 10.1136/jclinpath-2019-205795. Epub 2019 Jul 17.